Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1997 Sep;105(Suppl 5):1069–1072. doi: 10.1289/ehp.97105s51069

Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers.

J M Marsella 1, B L Liu 1, C A Vaslet 1, A B Kane 1
PMCID: PMC1470134  PMID: 9400702

Abstract

Exposure of mesothelial cells to asbestos fibers in vitro has been shown to induce DNA damage mediated by oxidants. An early cellular response to DNA damage is increased expression of the p53 protein. This protein induces transcription of genes that activate cell cycle checkpoints or induce apoptosis. A murine mesothelial cell line that spontaneously acquired a point mutation in the p53 gene shows increased sensitivity to DNA damage induced by crocidolite asbestos fibers. It is hypothesized that p53-deficient mice will show increased sensitivity to the genotoxic effects of asbestos and accelerated development of malignant mesotheliomas.

Full text

PDF
1069

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BéruBé K. A., Quinlan T. R., Fung H., Magae J., Vacek P., Taatjes D. J., Mossman B. T. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol. 1996 Jul;15(1):141–147. doi: 10.1165/ajrcmb.15.1.8679218. [DOI] [PubMed] [Google Scholar]
  2. Carbone M., Pass H. I., Rizzo P., Marinetti M., Di Muzio M., Mew D. J., Levine A. S., Procopio A. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994 Jun;9(6):1781–1790. [PubMed] [Google Scholar]
  3. Chao C. C., Park S. H., Aust A. E. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophys. 1996 Feb 1;326(1):152–157. doi: 10.1006/abbi.1996.0059. [DOI] [PubMed] [Google Scholar]
  4. Cistulli C. A., Sorger T., Marsella J. M., Vaslet C. A., Kane A. B. Spontaneous p53 mutation in murine mesothelial cells: increased sensitivity to DNA damage induced by asbestos and ionizing radiation. Toxicol Appl Pharmacol. 1996 Nov;141(1):264–271. doi: 10.1006/taap.1996.0283. [DOI] [PubMed] [Google Scholar]
  5. Cross S. M., Sanchez C. A., Morgan C. A., Schimke M. K., Ramel S., Idzerda R. L., Raskind W. H., Reid B. J. A p53-dependent mouse spindle checkpoint. Science. 1995 Mar 3;267(5202):1353–1356. doi: 10.1126/science.7871434. [DOI] [PubMed] [Google Scholar]
  6. Davis J. M., Dungworth D. L., Boorman G. A. Concordance in diagnosis of mesotheliomas. Toxicol Pathol. 1996 Sep-Oct;24(5):662–663. doi: 10.1177/019262339602400527. [DOI] [PubMed] [Google Scholar]
  7. Donehower L. A., Harvey M., Vogel H., McArthur M. J., Montgomery C. A., Jr, Park S. H., Thompson T., Ford R. J., Bradley A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog. 1995 Sep;14(1):16–22. doi: 10.1002/mc.2940140105. [DOI] [PubMed] [Google Scholar]
  8. Dong H., Buard A., Renier A., Lévy F., Saint-Etienne L., Jaurand M. C. Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro. Carcinogenesis. 1994 Jun;15(6):1251–1255. doi: 10.1093/carcin/15.6.1251. [DOI] [PubMed] [Google Scholar]
  9. Friedman M. T., Gentile P., Tarectecan A., Fuchs A. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Arch Pathol Lab Med. 1996 Oct;120(10):959–966. [PubMed] [Google Scholar]
  10. Goodglick L. A., Kane A. B. Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res. 1990 Aug 15;50(16):5153–5163. [PubMed] [Google Scholar]
  11. Goodglick L. A., Kane A. B. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res. 1986 Nov;46(11):5558–5566. [PubMed] [Google Scholar]
  12. Harvey M., Sands A. T., Weiss R. S., Hegi M. E., Wiseman R. W., Pantazis P., Giovanella B. C., Tainsky M. A., Bradley A., Donehower L. A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene. 1993 Sep;8(9):2457–2467. [PubMed] [Google Scholar]
  13. Hei T. K., He Z. Y., Suzuki K. Effects of antioxidants on fiber mutagenesis. Carcinogenesis. 1995 Jul;16(7):1573–1578. doi: 10.1093/carcin/16.7.1573. [DOI] [PubMed] [Google Scholar]
  14. Heineman E. F., Bernstein L., Stark A. D., Spirtas R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer. 1996 Feb 1;77(3):549–554. doi: 10.1002/(SICI)1097-0142(19960201)77:3<549::AID-CNCR18>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  15. Kafiri G., Thomas D. M., Shepherd N. A., Krausz T., Lane D. P., Hall P. A. p53 expression is common in malignant mesothelioma. Histopathology. 1992 Oct;21(4):331–334. doi: 10.1111/j.1365-2559.1992.tb00403.x. [DOI] [PubMed] [Google Scholar]
  16. Ko L. J., Prives C. p53: puzzle and paradigm. Genes Dev. 1996 May 1;10(9):1054–1072. doi: 10.1101/gad.10.9.1054. [DOI] [PubMed] [Google Scholar]
  17. Lee J. M., Abrahamson J. L., Kandel R., Donehower L. A., Bernstein A. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene. 1994 Dec;9(12):3731–3736. [PubMed] [Google Scholar]
  18. Livingstone L. R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 1992 Sep 18;70(6):923–935. doi: 10.1016/0092-8674(92)90243-6. [DOI] [PubMed] [Google Scholar]
  19. Mayall F. G., Goddard H., Gibbs A. R. The frequency of p53 immunostaining in asbestos-associated mesotheliomas and non-asbestos-associated mesotheliomas. Histopathology. 1993 Apr;22(4):383–386. doi: 10.1111/j.1365-2559.1993.tb00140.x. [DOI] [PubMed] [Google Scholar]
  20. McClellan R. O., Miller F. J., Hesterberg T. W., Warheit D. B., Bunn W. B., Kane A. B., Lippmann M., Mast R. W., McConnell E. E., Reinhardt C. F. Approaches to evaluating the toxicity and carcinogenicity of man-made fibers: summary of a workshop held November 11-13, 1991, Durham, North Carolina. Regul Toxicol Pharmacol. 1992 Dec;16(3):321–364. doi: 10.1016/0273-2300(92)90011-w. [DOI] [PubMed] [Google Scholar]
  21. Metcalf R. A., Welsh J. A., Bennett W. P., Seddon M. B., Lehman T. A., Pelin K., Linnainmaa K., Tammilehto L., Mattson K., Gerwin B. I. p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res. 1992 May 1;52(9):2610–2615. [PubMed] [Google Scholar]
  22. Moalli P. A., MacDonald J. L., Goodglick L. A., Kane A. B. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am J Pathol. 1987 Sep;128(3):426–445. [PMC free article] [PubMed] [Google Scholar]
  23. Moyer V. D., Cistulli C. A., Vaslet C. A., Kane A. B. Oxygen radicals and asbestos carcinogenesis. Environ Health Perspect. 1994 Dec;102 (Suppl 10):131–136. doi: 10.1289/ehp.94102s10131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Richburg J. H., Boekelheide K. Mono-(2-ethylhexyl) phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol Appl Pharmacol. 1996 Mar;137(1):42–50. doi: 10.1006/taap.1996.0055. [DOI] [PubMed] [Google Scholar]
  25. Sands A., Donehower L. A., Bradley A. Gene-targeting and the p53 tumor-suppressor gene. Mutat Res. 1994 Jun 1;307(2):557–572. doi: 10.1016/0027-5107(94)90266-6. [DOI] [PubMed] [Google Scholar]
  26. Segers K., Backhovens H., Singh S. K., De Voecht J., Ramael M., Van Broeckhoven C., Van Marck E. Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma. Virchows Arch. 1995;427(4):431–436. doi: 10.1007/BF00199393. [DOI] [PubMed] [Google Scholar]
  27. Smith M. L., Fornace A. J., Jr The two faces of tumor suppressor p53. Am J Pathol. 1996 Apr;148(4):1019–1022. [PMC free article] [PubMed] [Google Scholar]
  28. Symonds H., Krall L., Remington L., Saenz-Robles M., Lowe S., Jacks T., Van Dyke T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 1994 Aug 26;78(4):703–711. doi: 10.1016/0092-8674(94)90534-7. [DOI] [PubMed] [Google Scholar]
  29. Taguchi T., Jhanwar S. C., Siegfried J. M., Keller S. M., Testa J. R. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res. 1993 Sep 15;53(18):4349–4355. [PubMed] [Google Scholar]
  30. Thomas G., Ando T., Verma K., Kagan E. Asbestos fibers and interferon-gamma up-regulate nitric oxide production in rat alveolar macrophages. Am J Respir Cell Mol Biol. 1994 Dec;11(6):707–715. doi: 10.1165/ajrcmb.11.6.7524571. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES